Cancer survivors face higher medical costs and productivity losses when compared to people without a cancer history, according to a CDC study published June 13.
The Centers for Medicare and Medicaid Services have another six months to decide whether to cover low-dose computed tomography screening. Yet, proponents of screening seem unwilling to take the chance that Medicare coverage would be restrictive.
We are facing a disturbing paradox in science. We have unprecedented potential for advancements spurred by current technologies. But at the same time we are confronting flat to declining funding.
The Orphan Drug ImbroglioThe controversy over HRSA's authority emerged late last year, when the agency published a legislative rule that sought to provide coverage for some uses of orphan drugs.
Many people love the 340B Drug Pricing Program.
GEORGETOWN LOMBARDI COMPREHENSIVE CANCER CENTER and JOHN THEURER CANCER CENTER formed an immunotherapy research collaboration.
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO is encouraging cancer researchers to recruit more Hispanics in clinical trials to reduce health disparities.
THE NATIONAL PATIENT ADVOCATE FOUNDATION has launched Project Innovation, a movement to accelerate the pace of cancer medical discovery and to get therapies to patients quickly.
MAURIE MARKMAN was named president of the Medicine & Science unit of the Cancer Treatment Centers of America.
THE JOHNS HOPKINS UNIVERSITY received a $15 million pledge to help create a new bladder cancer institute.
